Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration

Veronica Caraffini, Bianca Perfler, Johannes Lorenz Berg, Barbara Uhl, Silvia Schauer, Karl Kashofer, Nassim Ghaffari-Tabrizi-Wizsy, Herbert Strobl, Albert Wölfler, Gerald Hoefler, Heinz Sill, Armin Zebisch

Blood (2018) 131 (7): 826–830.

https://doi.org/10.1182/blood-2017-09-804906

Published: 2018

Includes: Supplemental data

Journal Articles

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia

Blood (2017) 129 (18): 2587–2591.

https://doi.org/10.1182/blood-2016-11-751008

Published: 2017

Includes: Supplemental data

Journal Articles

Histiocytis Sarcoma-Targeted Therapy: Novel Therapeutic Options? A Series of 4 Cases

Konstantin Schlick, Martin Pichler, Sonja Reitter, Peter Neumeister, Gerald Hoefler, Christine Beham-Schmid, Werner Linkesch, Dirk Strunk, Ariane Aigelsreiter

Blood (2011) 118 (21): 5005.

https://doi.org/10.1182/blood.V118.21.5005.5005

Published: 2011

Journal Articles

New and Highly Efficient Therapy for Treatment NPM-ALK Associated Lymphomas

Lukas Kenner, Daniela Laimer, Helmut Dolznig, Paul Vesely, Karoline Kollmann, Ana-Iris Iris Schiefer, Veronika Sexl, MD, Philipp B Staber, M.D., Gerald Hoefler, Josef Penninger, Giorgio Inghirami, Jaeger Ulrich

Blood (2011) 118 (21): 1659.

https://doi.org/10.1182/blood.V118.21.1659.1659

Published: 2011

Journal Articles

Identification of Critical Phosporylation Sites within NPM-ALK That Regulate JUNB mRNA Translation.

Claudia Fuchs, Paul Vesely, Ms, Isabella Bambach, Silvia Schauer, Werner Linkesch, MD, David W. Sternberg, MD, PhD, Gerald Hoefler, MD, Philipp B. Staber, MD

Blood (2007) 110 (11): 3571.

https://doi.org/10.1182/blood.V110.11.3571.3571

Published: 2007

Journal Articles

The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling

Philipp B. Staber, Paul Vesely, Naznin Haq, Rene G. Ott, Kotaro Funato, Isabella Bambach, Claudia Fuchs, Silvia Schauer, Werner Linkesch, Andelko Hrzenjak, Wilhelm G. Dirks, Veronika Sexl, Helmut Bergler, Marshall E. Kadin, David W. Sternberg, Lukas Kenner, Gerald Hoefler

Blood (2007) 110 (9): 3374–3383.

https://doi.org/10.1182/blood-2007-02-071258

Published: 2007

Includes: Supplemental data

Journal Articles

NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Exerts Its Transforming Potential by Increasing Translation of JUNB through mTOR and S6K1.

Philipp B. Staber, MD, Paul Vesely, MS, Rene Ott, PhD, Naznin Haq, Werner Linkesch, MD, Silvia Schauer, Andelko Hrzenjak, PhD, Lukas Kenner, MD, Wilhelm Dirks, PhD, Marshall E. Kadin, MD, David W. Sternberg, MD PhD, Gerald Hoefler, MD

Blood (2006) 108 (11): 1428.

https://doi.org/10.1182/blood.V108.11.1428.1428

Published: 2006

Journal Articles

NPM-ALK Converts JUNB from a Tumor Suppressor to an Oncogene.

Paul Vesely, MS, Philipp B. Staber, MD, Rene Ott, PhD, Montserrat Pinent, PhD, Werner Linkesch, MD, Silvia Schauer, Andelko Hrzenjak, PhD, Marshall E. Kadin, MD, David W. Sternberg, MD PhD, Gerald Hoefler, MD

Blood (2006) 108 (11): 1448.

https://doi.org/10.1182/blood.V108.11.1448.1448

Published: 2006

Journal Articles

Genes Regulated by NPM-ALK Fusion Kinase Play a Key Role in the Activation of AP-1 Transcription Factors.

Philipp B. Staber, MD, Werner Linkesch, MD, Silvia Schauer, Gerit Moser, Marshall E. Kadin, MD, Willi Dirks, PhD, Gerald Hoefler, MD

Blood (2004) 104 (11): 245.

https://doi.org/10.1182/blood.V104.11.245.245

Published: 2004

Journal Articles

Two Novel Activating Germline Mutations of the C-RAF Proto-Oncogene Predisposing to Solid Tumors and Therapy-Related Acute Myeloid Leukemia.

Armin Zebisch, MD, Philipp B. Staber, MD, Katja Fischereder, Claudia Bodner, Karin Hiden, Werner Linkesch, MD, Holger W. Auner, MD, Werner Emberger, MD, Christian Windpassinger, PhD, Michael G. Schimek, PhD, Gerald Hoefler, MD, Jakob Troppmair, PhD, Heinz Sill, MD

Blood (2004) 104 (11): 3370.

https://doi.org/10.1182/blood.V104.11.3370.3370

Published: 2004

NARROW

Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia

Histiocytis Sarcoma-Targeted Therapy: Novel Therapeutic Options? A Series of 4 Cases

New and Highly Efficient Therapy for Treatment NPM-ALK Associated Lymphomas

Identification of Critical Phosporylation Sites within NPM-ALK That Regulate JUNB mRNA Translation.

The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling

NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Exerts Its Transforming Potential by Increasing Translation of JUNB through mTOR and S6K1.

NPM-ALK Converts JUNB from a Tumor Suppressor to an Oncogene.

Genes Regulated by NPM-ALK Fusion Kinase Play a Key Role in the Activation of AP-1 Transcription Factors.

Two Novel Activating Germline Mutations of the C-RAF Proto-Oncogene Predisposing to Solid Tumors and Therapy-Related Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only